A simple and rapid synthesis of nucleotide analogues containing a phosphorothioate moiety at the terminal position of the phosphate chain

Tetrahedron Letters

Volumn 48, Issue 31, 2007, Pages 5475-5479

  Kowalska, Joanna ^a   Lewdorowicz, Magdalena ^a   Darzynkiewicz, Edward ^a   Jemielity, Jacek ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Chemical synthesis; Nucleotide analogues; Phosphorimidazolides; Phosphorothioates

Indexed keywords

2' DEOXYCYTIDINE 5' (2 THIODIPHOSPHATE); 7 METHYLGUANOSINE 5' (2 THIODIPHOSPHATE); 7 METHYLGUANOSINE 5' (3 THIOTRIPHOSPHATE); ADENOSINE 5' (2 THIODIPHOSPHATE); ADENOSINE 5' DIPHOSPHATE IMIDAZOLIDE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE 5' (2 THIODIPHOSPHATE); GUANOSINE 5' (3 THIOTRIPHOSPHATE); GUANOSINE 5' PHOSPHORIMIDAZOLIDE; INOSINE 5' (2 THIODIPHOSPHATE); NUCLEOSIDE 5' (2 THIODIPHOSPHATE); NUCLEOSIDE 5' (3 THIOTRIPHOSPHATE); NUCLEOTIDE DERIVATIVE; PHOSPHORIMIDAZOLIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; UNCLASSIFIED DRUG; URIDINE 5' (2 THIODIPHOSPHATE);

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SYNTHESIS;

EID: 34347326069     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.05.170     Document Type: Article

References (35)

1. Eckstein F. Annu. Rev. Biochem. 54 (1985) 367-402
2. Sheu K.F., Richard J.P., and Frey P.A. Biochemistry 18 (1979) 5548-5556
3. Eckstein F., Cassel D., Levkovitz H., Lowe M., and Selinger Z. J. Biol. Chem. 254 (1979) 9829-9834
4. Gurer C., Hoglund A., Hoglund S., and Luban J. J. Virol. 79 (2005) 5557-5567
5. Oshevski S.I. FEBS Lett. 143 (1982) 119-123
6. Boutorine A.S., Le Doan T., Battioni J.P., Mansuy D., Dupre D., and Helene C. Bioconjugate Chem. 1 (1990) 350-356
7. Sun I.Y., Johnson E.M., and Allfrey V.G. J. Biol. Chem. 255 (1980) 742-747
8. Cassel D., and Glaser L. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 2231-2235
9. Kenney R.E., Hoar P.E., and Kerrick W.G. J. Biol. Chem. 265 (1990) 8642-8649
10. Weinstock G.M., McEntee K., and Lehman I.R. J. Biol. Chem. 256 (1981) 8850-8855
11. Merwe P.A., Millar R.P., Wakefield I.K., and Davidson J.S. Biochem. J. 275 (1991) 399-405 (Pt 2)
12. Malinski J.A., Zera E.M., Angleson J.K., and Wensel T.G. J. Biol. Chem. 271 (1996) 12919-12924
13. Malmsjo M., Hou M., Pendergast W., Erlinge D., and Edvinsson L. Eur. J. Pharmacol. 458 (2003) 305-311
14. Draganescu A., Hodawadekar S.C., Gee K.R., and Brenner C. J. Biol. Chem. 275 (2000) 4555-4560
15. Alefelder S., Patel B.K., and Eckstein F. Nucleic Acids Res. 26 (1998) 4983-4988
16. Goody R.S., Eckstein F., and Schirmer R.H. Biochim. Biophys. Acta 276 (1972) 155-161
17. Lazarowski E.R., Watt W.C., Stutts M.J., Brown H.A., Boucher R.C., and Harden T.K. Br. J. Pharmacol. 117 (1996) 203-209
18. Goody R.S., and Eckstein F. J. Am. Chem. Soc. 93 (1971) 6252-6257
19. Richard J.P., Ho H.T., and Frey P.A. J. Am. Chem. Soc. 100 (1978) 7756-7757
20. Richard J.P., and Frey P.A. J. Am. Chem. Soc. 100 (1978) 7757-7758
21. Richard J.P., and Frey P.A. J. Am. Chem. Soc. 104 (1982) 3476-3481
22. Michelson A.M. Biochim. Biophys. Acta 91 (1964) 1-13
23. Cai A., Jankowska-Anyszka M., Centers A., Chlebicka L., Stepinski J., Stolarski R., Darzynkiewicz E., and Rhoads R.E. Biochemistry 38 (1999) 8538-8547
24. Kadokura M., Wada T., Urashima C., and Sekine M. Tetrahedron Lett. 38 (1997) 8359-8362
25. Stepinski J., Waddell C., Stolarski R., Darzynkiewicz E., and Rhoads R.E. RNA 7 (2001) 1486-1495
26. Jemielity J., Fowler T., Zuberek J., Stepinski J., Lewdorowicz M., Niedzwiecka A., Stolarski R., Darzynkiewicz E., and Rhoads R.E. RNA 9 (2003) 1108-1122
27. Guranowski A., Starzynska E., Pietrowska-Borek M., Jemielity J., Kowalska J., Darzynkiewicz E., Thompson M.J., and Blackburn G.M. FEBS J. 273 (2006) 829-838
28. Kalek M., Jemielity J., Darzynkiewicz Z.M., Bojarska E., Stepinski J., Stolarski R., Davis R.E., and Darzynkiewicz E. Bioorg. Med. Chem. 14 (2006) 3223-3230
29. Nahum V., Tulapurkar M., Levesque S.A., Sevigny J., Reiser G., and Fischer B. J. Med. Chem. 49 (2006) 1980-1990
30. Shimazu M., Shinozuka K., and Sawai H. Tetrahedron Lett. 31 (1990) 235-238
31. Mukaiyama T., and Hashimoto M. Bull. Chem. Soc. Jpn. 44 (1971) 2284
32. Sawai H., Wakai H., and Nakamura-Ozaki A. J. Org. Chem. 64 (1999) 5836-5840
33. Darzynkiewicz E., Ekiel I., Tahara S.M., Seliger L.S., and Shatkin A.J. Biochemistry 24 (1985) 1701-1707
34. Compounds 1a-d and 2a were prepared in large-scale reactions (starting from 100 to 150 mg of the respective imidazolide derivative). These compounds were isolated as triethylammonium salts after Sephadex ion-exchange chromatography. Compounds 1e, 1f, 2b and 2c were prepared in small scale reactions (starting from ca. 20 mg of the respective imidazolide). These compounds were isolated as ammonium salts after semi-preparative RP HPLC separation.
35. 7GMP, UMP and dCMP required about a 2-fold larger excess of imidazole and other reagents than described for GMP to achieve efficient conversion into phosphorimidazolides.